Prevention of doxorubicin-induced cardiotoxicity by recombinant interleukin-1 in hamsters

[1]  R. DiSilvestro,et al.  Interleukin 1 Slowly Increases Lung Fibroblast Cu-Zn Superoxide Dismutase Activity Levels , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2]  M. Green,et al.  Role of (+-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy. , 1990, Cancer research.

[3]  M. Moore,et al.  Effects of IL-1 on hematopoietic progenitors after myelosuppressive chemoradiotherapy , 1989, Biotherapy.

[4]  D. Longo,et al.  Induction of mitochondrial manganese superoxide dismutase by interleukin 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  D. Goeddel,et al.  Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism , 1988, Science.

[6]  R. Neta,et al.  Cytokines in therapy of radiation injury. , 1988, Blood.

[7]  I. Mavelli,et al.  Prevention by fructose-1,6-bisphosphate of cardiac oxidative damage induced in mice by subchronic doxorubicin treatment. , 1987, Cancer research.

[8]  Satsuki Nakai,et al.  Purification and characterization of recombinant human interleukin-1 produced in Escherichia coli , 1987 .

[9]  T. Nishida,et al.  cDNA cloning of IL-1α and IL-1β from mRNA of U937 cell line , 1987 .

[10]  R. Neta,et al.  Interleukin 1 is a radioprotector. , 1986, Journal of immunology.

[11]  M. Yamada,et al.  Efficient production of a human tumour necrosis factor in Escherichia coli. , 1985, Nucleic acids symposium series.

[12]  R. Hamlin,et al.  Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin. , 1985, Journal of applied physiology.

[13]  K. Kawahara,et al.  Purification and characterization of recombinant human interleukin-2 produced in Escherichia coli. , 1985, Biochemical and biophysical research communications.

[14]  Paul J Thornalley,et al.  Free radical production from normal and adriamycin-treated rat cardiac sarcosomes. , 1985, Biochemical pharmacology.

[15]  J. Fisher,et al.  Direct enzyme-catalyzed reduction of anthracyclines by reduced nicotinamide adenine dinucleotide. , 1983, Biochemistry.

[16]  J. Doroshow,et al.  Mitochondrial NADH dehydrogenase‐catalyzed oxygen radical production by adriamycin, and the relative inactivity of 5‐iminodaunorubicin , 1983, FEBS letters.

[17]  G. Yee,et al.  The anticancer agent adriamycin can be actively cytotoxic without entering cells. , 1982, Science.

[18]  J. Doroshow,et al.  Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. , 1981, The Journal of clinical investigation.

[19]  W. Haseltine,et al.  Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen. , 1981, The Journal of biological chemistry.

[20]  Y. M. Wang,et al.  Effect of vitamin E against adriamycin-induced toxicity in rabbits. , 1980, Cancer research.

[21]  E. Goormaghtigh,et al.  Evidence of a specific complex between adriamycin and negatively-charged phospholipids. , 1980, Biochimica et biophysica acta.

[22]  T. Oki,et al.  A comparative electron microscopic study of aclacinomycin and adriamycin cardiotoxicities in rabbits and hamsters. , 1980, Journal of electron microscopy.

[23]  N. Bachur,et al.  NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Marušić,et al.  Glutathione peroxidase activity and selenium concentration in the hearts of doxorubicin-treated rabbits. , 1978, Journal of molecular and cellular cardiology.

[25]  W. S. Thayer.  Adriamycin stimulated superoxide formation in submitochondrial particles. , 1977, Chemico-biological interactions.

[26]  J. Ward,et al.  Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats. , 1977, Cancer research.

[27]  P. Hochstein,et al.  Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. , 1977, Biochemical and biophysical research communications.

[28]  I. Ifrim,et al.  Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. , 1977, Science.

[29]  K. Handa,et al.  Generation of free radicals of quinone group-containing anti-cancer chemicals in NADPH-microsome system as evidenced by initiation of sulfite oxidation. , 1975, Gan.

[30]  L. Mawdesley-Thomas.  Research into Fish Diseases , 1972, Nature.

[31]  W. Pigram,et al.  Stereochemistry of intercalation: interaction of daunomycin with DNA. , 1972, Nature: New biology.

[32]  E. Herman,et al.  Influence of pharmacologic or physiologic pretreatment on acute daunomycin cardiac toxicity in the hamster. , 1970, Toxicology and applied pharmacology.

[33]  H. Uchino,et al.  DEPARTMENT OF INTERNAL MEDICINE , 1966 .